Although few studies have focused on GATA2 in the progression of CRC, we found that GATA2 is targeted by known CRC microRNA (e.g., hsa-mir-13237, has-mir-2538), resulting in decreased or silenced gene expression. This evidence concerns the gene GATA2 and colorectal carcinoma.